Oleic acid released by sensory neurons inhibits TRPV1-mediated thermal hypersensitivity via GPR40.

Biological sciences Molecular neuroscience Neuroscience Sensory neuroscience

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
16 Aug 2024
Historique:
received: 23 01 2024
revised: 17 06 2024
accepted: 17 07 2024
medline: 22 8 2024
pubmed: 22 8 2024
entrez: 22 8 2024
Statut: epublish

Résumé

Noxious stimuli activate nociceptive sensory neurons, causing action potential firing and the release of diverse signaling molecules. Several peptides have already been identified to be released by sensory neurons and shown to modulate inflammatory responses and inflammatory pain. However, it is still unclear whether lipid mediators can be released upon sensory neuron activation to modulate intercellular communication. Here, we analyzed the lipid secretome of capsaicin-stimulated nociceptive neurons with LC-HRMS, revealing that oleic acid is strongly released from sensory neurons by capsaicin. We further demonstrated that oleic acid inhibits capsaicin-induced calcium transients in sensory neurons and reverses bradykinin-induced TRPV1 sensitization by a calcineurin (CaN) and GPR40 (FFAR1) dependent pathway. Additionally, oleic acid alleviated zymosan-mediated thermal hypersensitivity via the GPR40, suggesting that the capsaicin-mediated oleic acid release from sensory neurons acts as a protective and feedback mechanism, preventing sensory neurons from nociceptive overstimulation via the GPR40/CaN/TRPV1-axis.

Identifiants

pubmed: 39171292
doi: 10.1016/j.isci.2024.110552
pii: S2589-0042(24)01777-2
pmc: PMC11338150
doi:

Types de publication

Journal Article

Langues

eng

Pagination

110552

Informations de copyright

© 2024 The Author(s).

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Auteurs

Maksim Sendetski (M)

Goethe University Frankfurt, University Hospital, Institute of Clinical Pharmacology, Theodor-Stern-Kai 7, 60590 Frankfurt Am Main, Germany.

Saskia Wedel (S)

Goethe University Frankfurt, University Hospital, Institute of Clinical Pharmacology, Theodor-Stern-Kai 7, 60590 Frankfurt Am Main, Germany.

Kenta Furutani (K)

Department of Anesthesiology, Center for Translational Pain Medicine, Duke University Medical Center, Durham, NC, USA.

Lisa Hahnefeld (L)

Goethe University Frankfurt, University Hospital, Institute of Clinical Pharmacology, Theodor-Stern-Kai 7, 60590 Frankfurt Am Main, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor Stern-Kai 7, 60596 Frankfurt Am Main, Germany.
Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (CIMD), Theodor Stern-Kai 7, 60596 Frankfurt Am Main, Germany.

Carlo Angioni (C)

Goethe University Frankfurt, University Hospital, Institute of Clinical Pharmacology, Theodor-Stern-Kai 7, 60590 Frankfurt Am Main, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor Stern-Kai 7, 60596 Frankfurt Am Main, Germany.

Jan Heering (J)

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor Stern-Kai 7, 60596 Frankfurt Am Main, Germany.

Béla Zimmer (B)

Goethe University Frankfurt, University Hospital, Institute of Clinical Pharmacology, Theodor-Stern-Kai 7, 60590 Frankfurt Am Main, Germany.

Sandra Pierre (S)

Goethe University Frankfurt, University Hospital, Institute of Clinical Pharmacology, Theodor-Stern-Kai 7, 60590 Frankfurt Am Main, Germany.

Alexandra-Maria Banica (AM)

Cell Signalling Research Group, Institute of Biochemistry of the Romanian Academy, Splaiul Independentei 296, 060031 Bucharest, Romania.

Klaus Scholich (K)

Goethe University Frankfurt, University Hospital, Institute of Clinical Pharmacology, Theodor-Stern-Kai 7, 60590 Frankfurt Am Main, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor Stern-Kai 7, 60596 Frankfurt Am Main, Germany.

Sorin Tunaru (S)

Cell Signalling Research Group, Institute of Biochemistry of the Romanian Academy, Splaiul Independentei 296, 060031 Bucharest, Romania.

Gerd Geisslinger (G)

Goethe University Frankfurt, University Hospital, Institute of Clinical Pharmacology, Theodor-Stern-Kai 7, 60590 Frankfurt Am Main, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor Stern-Kai 7, 60596 Frankfurt Am Main, Germany.
Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (CIMD), Theodor Stern-Kai 7, 60596 Frankfurt Am Main, Germany.

Ru-Rong Ji (RR)

Department of Anesthesiology, Center for Translational Pain Medicine, Duke University Medical Center, Durham, NC, USA.
Departments of Cell Biology and Neurobiology, Duke University Medical Center, Durham, NC, USA.

Marco Sisignano (M)

Goethe University Frankfurt, University Hospital, Institute of Clinical Pharmacology, Theodor-Stern-Kai 7, 60590 Frankfurt Am Main, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor Stern-Kai 7, 60596 Frankfurt Am Main, Germany.
Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (CIMD), Theodor Stern-Kai 7, 60596 Frankfurt Am Main, Germany.

Classifications MeSH